ML-T7

• CAT Number: I040149
• CAS Number: 459789-75-4
• Molecular Formula: C27H17Cl2NO5
• Molecular Weight: 506.33
• Purity: ≥95%
• Synonyms: 5-(2,4-dichlorophenyl)-1-(4-methylphenyl)spiro[3a,6a-dihydro-1H-furo[3,4-c]pyrrole-3,2′-indene]-1′,3′,4,6-tetrone
• InChI: InChI=1S/C27H17Cl2NO5/c1-13-6-8-14(9-7-13)22-20-21(26(34)30(25(20)33)19-11-10-15(28)12-18(19)29)27(35-22)23(31)16-4-2-3-5-17(16)24(27)32/h2-12,20-22H,1H3
• InChIKey: OFJOQMMYCMPPEC-UHFFFAOYSA-N
• SMILES: CC1=CC=C(C=C1)C2C3C(C(=O)N(C3=O)C4=C(C=C(C=C4)Cl)Cl)C5(O2)C(=O)C6=CC=CC=C6C5=O

ML-T7 (Cat No.: I040149) is a small-molecule compound known for its potential in targeting specific biological pathways, often in the context of cancer research or inflammation modulation. While its precise mechanism of action may vary, ML-T7 is typically used to inhibit key enzymes or receptors involved in disease progression. Its application in preclinical studies suggests it may affect tumor growth, immune cell regulation, or other disease-related processes. Due to its specificity, ML-T7 holds promise as a therapeutic candidate for targeted treatment strategies.

Reference

[1]. Ma S, et al. Identification of a small-molecule Tim-3 inhibitor to potentiate T cell-mediated antitumor immunotherapy in preclinical mouse models. Sci Transl Med. 2023 Nov 15;15(722):eadg6752.
[Content Brief]